In silico screening for human norovirus antivirals reveals a novel non-nucleoside inhibitor of the viral polymerase

[1]  A. Brancale,et al.  Broad‐spectrum non‐nucleoside inhibitors for caliciviruses , 2017, Antiviral research.

[2]  A. Brancale,et al.  Shape-based virtual screening, synthesis and evaluation of novel pyrrolone derivatives as antiviral agents against HCV. , 2017, Bioorganic & medicinal chemistry letters.

[3]  D. Graham,et al.  Replication of human noroviruses in stem cell–derived human enteroids , 2016, Science.

[4]  J. Neyts,et al.  Inhibition of human norovirus by a viral polymerase inhibitor in the B cell culture system and in the mouse model. , 2016, Antiviral research.

[5]  Chao Zhang,et al.  Design, synthesis and evaluation of novel tacrine-multialkoxybenzene hybrids as multi-targeted compounds against Alzheimer's disease. , 2016, European journal of medicinal chemistry.

[6]  T. Cihlar,et al.  Current status and prospects of HIV treatment. , 2016, Current opinion in virology.

[7]  Sachiko Ozawa,et al.  Global Economic Burden of Norovirus Gastroenteritis , 2016, PloS one.

[8]  P. White,et al.  Purification and Biochemical Characterisation of Rabbit Calicivirus RNA-Dependent RNA Polymerases and Identification of Non-Nucleoside Inhibitors , 2016, Viruses.

[9]  Ishani Behera,et al.  Biochemical Evaluation of the Inhibition Properties of Favipiravir and 2′-C-Methyl-Cytidine Triphosphates against Human and Mouse Norovirus RNA Polymerases , 2015, Antimicrobial Agents and Chemotherapy.

[10]  N. Verdaguer,et al.  RNA-Dependent RNA Polymerases of Picornaviruses: From the Structure to Regulatory Mechanisms , 2015, Viruses.

[11]  S. Wallet,et al.  Enteric bacteria promote human and mouse norovirus infection of B cells , 2014, Science.

[12]  P. White,et al.  Cross-Genotypic Examination of Hepatitis C Virus Polymerase Inhibitors Reveals a Novel Mechanism of Action for Thumb Binders , 2014, Antimicrobial Agents and Chemotherapy.

[13]  O. Weiland,et al.  ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotype 1b infection. , 2014, Gastroenterology.

[14]  M. Bolognesi,et al.  PPNDS inhibits murine Norovirus RNA‐dependent RNA‐polymerase mimicking two RNA stacking bases , 2014, FEBS letters.

[15]  K. Green,et al.  Treatment of norovirus infections: moving antivirals from the bench to the bedside. , 2014, Antiviral research.

[16]  M. Bolognesi,et al.  Delivery of Suramin as an Antiviral Agent through Liposomal Systems , 2014, ChemMedChem.

[17]  J. Mackenzie,et al.  Nonnucleoside Inhibitors of Norovirus RNA Polymerase: Scaffolds for Rational Drug Design , 2014, Antimicrobial Agents and Chemotherapy.

[18]  M. Bolognesi,et al.  Structural Bases of Norovirus RNA Dependent RNA Polymerase Inhibition by Novel Suramin-Related Compounds , 2014, PloS one.

[19]  M. Bolognesi,et al.  Naphthalene-sulfonate inhibitors of human norovirus RNA-dependent RNA-polymerase. , 2014, Antiviral research.

[20]  D. Hua,et al.  Design, synthesis, and bioevaluation of viral 3C and 3C-like protease inhibitors , 2013, Bioorganic & Medicinal Chemistry Letters.

[21]  Manish M Patel,et al.  Clinical characteristics of norovirus-associated deaths: a systematic literature review. , 2013, American journal of infection control.

[22]  P. White,et al.  A Fluorescence-Based High-Throughput Screen to Identify Small Compound Inhibitors of the Genotype 3a Hepatitis C Virus RNA Polymerase , 2013, Journal of biomolecular screening.

[23]  John McNally,et al.  Sofosbuvir for previously untreated chronic hepatitis C infection. , 2013, The New England journal of medicine.

[24]  A. Coluccia,et al.  Computer-aided identification, design and synthesis of a novel series of compounds with selective antiviral activity against chikungunya virus. , 2013, Antiviral research.

[25]  K. Bok,et al.  Norovirus gastroenteritis in immunocompromised patients. , 2012, The New England journal of medicine.

[26]  Kerstin Pingel,et al.  50 Years of Image Analysis , 2012 .

[27]  Kevin W Eliceiri,et al.  NIH Image to ImageJ: 25 years of image analysis , 2012, Nature Methods.

[28]  M. Bolognesi,et al.  Structure-based inhibition of Norovirus RNA-dependent RNA polymerases. , 2012, Journal of molecular biology.

[29]  Wonsuk Chang,et al.  Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase. , 2012, Journal of medicinal chemistry.

[30]  P. Simister,et al.  An objective assessment of conformational variability in complexes of hepatitis C virus polymerase with non-nucleoside inhibitors. , 2011, Journal of molecular biology.

[31]  J. Adachi,et al.  Norovirus gastroenteritis successfully treated with nitazoxanide. , 2011, The Journal of infection.

[32]  G. Lushington,et al.  Design, synthesis, and evaluation of inhibitors of Norwalk virus 3C protease. , 2011, Bioorganic & medicinal chemistry letters.

[33]  M. Kretzschmar,et al.  Unspecified Gastroenteritis Illness and Deaths in the Elderly Associated With Norovirus Epidemics , 2011, Epidemiology.

[34]  T. Oka,et al.  Comparison of the replication properties of murine and human calicivirus RNA-dependent RNA polymerases , 2011, Virus Genes.

[35]  J. Cooper,et al.  A Structural Study of Norovirus 3C Protease Specificity: Binding of a Designed Active Site-Directed Peptide Inhibitor† , 2010, Biochemistry.

[36]  A. Simon,et al.  Clinical characteristics of viral intestinal infection in preterm and term neonates , 2010, European Journal of Clinical Microbiology & Infectious Diseases.

[37]  Artur M. S. Silva,et al.  (E)-2-styrylchromones as potential anti-norovirus agents. , 2010, Bioorganic & medicinal chemistry.

[38]  K. Rangappa,et al.  Inhibition of gastric H+, K+-ATPase by novel thiazolidinone derivatives , 2010 .

[39]  P. Tucker,et al.  Antiviral strategies to control calicivirus infections , 2010, Antiviral Research.

[40]  Steven‐Huy B. Han,et al.  A Systematic Review of Side Effects of Nucleoside and Nucleotide Drugs Used for Treatment of Chronic Hepatitis B , 2010, Current hepatitis reports.

[41]  T. Chou.  Drug combination studies and their synergy quantification using the Chou-Talalay method. , 2010, Cancer research.

[42]  Hiroyuki Tsutsumi,et al.  Detection of enteric viruses in rectal swabs from children with acute gastroenteritis attending the pediatric outpatient clinics in Sapporo, Japan. , 2009, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.

[43]  David M. Wilson,et al.  Identification and Characterization of Inhibitors of Human Apurinic/apyrimidinic Endonuclease APE1 , 2009, PloS one.

[44]  J. Rossignol,et al.  Nitazoxanide in the treatment of viral gastroenteritis: a randomized double‐blind placebo‐controlled clinical trial , 2006, Alimentary pharmacology & therapeutics.

[45]  Thomas Stützle,et al.  PLANTS: Application of Ant Colony Optimization to Structure-Based Drug Design , 2006, ANTS Workshop.

[46]  P. White,et al.  High-Affinity Aptamers to Subtype 3a Hepatitis C Virus Polymerase Display Genotypic Specificity , 2006, Antimicrobial Agents and Chemotherapy.

[47]  C. Rommel,et al.  Furan-2-ylmethylene thiazolidinediones as novel, potent, and selective inhibitors of phosphoinositide 3-kinase gamma. , 2006, Journal of medicinal chemistry.

[48]  Larissa B. Thackray,et al.  Murine Norovirus: a Model System To Study Norovirus Biology and Pathogenesis , 2006, Journal of Virology.

[49]  T. Fishbein,et al.  Characteristics of Human Calicivirus Enteritis in Intestinal Transplant Recipients , 2005, Journal of pediatric gastroenterology and nutrition.

[50]  R. Guerrant,et al.  Intestinal Barrier Function and Weight Gain in Malnourished Children Taking Glutamine Supplemented Enteral Formula , 2005, Journal of pediatric gastroenterology and nutrition.

[51]  Larissa B. Thackray,et al.  Replication of Norovirus in Cell Culture Reveals a Tropism for Dendritic Cells and Macrophages , 2004, PLoS biology.

[52]  Kenneth A. Johnson,et al.  Toxicity of nucleoside analogues used to treat AIDS and the selectivity of the mitochondrial DNA polymerase. , 2003, Biochemistry.

[53]  Lawrence C Kuo,et al.  Inhibition of Hepatitis C Virus RNA Replication by 2′-Modified Nucleoside Analogs* , 2003, The Journal of Biological Chemistry.

[54]  J. Mackey,et al.  Nucleoside analogues: mechanisms of drug resistance and reversal strategies , 2001, Leukemia.

[55]  X. Pang,et al.  Human caliciviruses in acute gastroenteritis of young children in the community. , 2000, The Journal of infectious diseases.

[56]  J. Mullins,et al.  Lethal mutagenesis of HIV with mutagenic nucleoside analogs. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[57]  B. Mandal,et al.  A randomized trial of acyclovir for 7 days or 21 days with and without prednisolone for treatment of acute herpes zoster. , 1994, The New England journal of medicine.

[58]  J. Mcvie,et al.  Synthesis and biological properties of side-chain-modified bleomycins. , 1987, Journal of medicinal chemistry.

[59]  P. Volberding,et al.  Lack of response to suramin in patients with AIDS and AIDS-related complex. , 1987, The American journal of medicine.

[60]  E. Gelmann,et al.  EFFECTS OF SURAMIN ON HTLV-III/LAV INFECTION PRESENTING AS KAPOSI'S SARCOMA OR AIDS-RELATED COMPLEX: CLINICAL PHARMACOLOGY AND SUPPRESSION OF VIRUS REPLICATION IN VIVO , 1985, The Lancet.

[61]  H. Yde.  EXPLORATION OF INDEPENDENCE. , 1964, Lancet.

[62]  C. Langdon,et al.  Efficacy and safety of fluocinolone acetonide 0.025% otic solution in patients with otic eczema:: a randomized, double-blind, placebocontrolled clinical trial , 2019 .

[63]  M. Kessentini,et al.  A Systematic Literature Review , 2016 .

[64]  Marie-Pierre de Béthune,et al.  Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009). , 2010, Antiviral research.

[65]  M. de Béthune.  Non-nucleoside reverse transcriptase inhibitors (NNRTIs), their discovery, development, and use in the treatment of HIV-1 infection: a review of the last 20 years (1989-2009). , 2010, Antiviral research.

[66]  G. Mantzaris,et al.  Lamivudine treatment for acute severe hepatitis B: report of a case and review of the literature. , 2008, Acta gastro-enterologica Belgica.

[67]  T Lengauer,et al.  CASP2 experiences with docking flexible ligands using FLEXX , 1997, Proteins.

[68]  Willard A. Burns,et al.  Report of a Case and Review of the Literature , 2017 .